tirzepatide weight loss trials New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss New drug tirzepatide delivers significant

Teva Pharmaceuticals gained approval for generic Saxenda

Let's be honest, though

Results Theories were identified to explain how features experienced by people may shape responses to care, and influence the mechanisms through which mental healthcare is expected to work

Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019

It says nothing about what's actually changing inside your body and on most modern interventions, the scale is the least useful number you can track